SARMs and CBD: Navigating Regulatory Gaps in UK's Food Industry - Unusual products blur the lines between food and medicine, prompting questions about effective regulation.
As government authorities come to grips with legislation of cannabis-based products, the European market holds a key position, Liam McGreevy, CEO, Ethnopharm Ltd explains.
A recent European Monitoring Centre for Drugs and Drug Addiction report highlights the need for diversity of cannabis products, increased potency and close monitoring of health effects.
Here, we find out about Fundación CANNA’s aim is to promote research and education about cannabis, including their strong focus on the effects of this on the human body.
GreenLight Pharmaceuticals Ltd is advancing clinical research and education in UK and Ireland; Though government progress on access and prescribing recommendations lags behind much of Europe.
Whether you see it as the “latest” health craze, have considered taking it yourself, or, have been relying on it for some time now, you may have asked: Can someone take too much CBD? Here, we find out.
CBDepot, a pioneer in the production of high-quality natural cannabinoid ingredients and a world-leading researcher highlights the work they conduct here.
The Minister for Health continues to tackle the issue of access to medical cannabis, unemployment and sustainable energy via the idea of peat bogs as medical cannabis farms.
The National Institute for Health and Care Excellence (NICE) said they need more research into CBD medicines before the NHS can prescribe them in general.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group shares a perspective on the present status and potential evolution when it comes to cannabinoids for therapeutic purposes.
